HK1109903A1 - Amide prodrug of gemcitabine, compositions and use thereof - Google Patents

Amide prodrug of gemcitabine, compositions and use thereof

Info

Publication number
HK1109903A1
HK1109903A1 HK08100464.9A HK08100464A HK1109903A1 HK 1109903 A1 HK1109903 A1 HK 1109903A1 HK 08100464 A HK08100464 A HK 08100464A HK 1109903 A1 HK1109903 A1 HK 1109903A1
Authority
HK
Hong Kong
Prior art keywords
gemcitabine
compositions
amide prodrug
prodrug
amide
Prior art date
Application number
HK08100464.9A
Other languages
English (en)
Inventor
David Michael Bender
David Michael Remick
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK1109903A1 publication Critical patent/HK1109903A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
HK08100464.9A 2004-12-17 2008-01-14 Amide prodrug of gemcitabine, compositions and use thereof HK1109903A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63742204P 2004-12-17 2004-12-17
PCT/US2005/043125 WO2006065525A1 (fr) 2004-12-17 2005-11-30 Promedicament amide de gemcitabine, compositions et utilisation associees

Publications (1)

Publication Number Publication Date
HK1109903A1 true HK1109903A1 (en) 2008-06-27

Family

ID=36168678

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08100464.9A HK1109903A1 (en) 2004-12-17 2008-01-14 Amide prodrug of gemcitabine, compositions and use thereof

Country Status (32)

Country Link
US (1) US7691827B2 (fr)
EP (1) EP1831237B1 (fr)
JP (1) JP5022911B2 (fr)
KR (1) KR100874052B1 (fr)
CN (1) CN101080417B (fr)
AR (1) AR055009A1 (fr)
AT (1) ATE405573T1 (fr)
AU (1) AU2005316922B2 (fr)
BR (1) BRPI0519117A2 (fr)
CA (1) CA2589850C (fr)
CY (1) CY1108447T1 (fr)
DE (1) DE602005009255D1 (fr)
DK (1) DK1831237T3 (fr)
EA (1) EA011868B1 (fr)
ES (1) ES2310860T3 (fr)
HK (1) HK1109903A1 (fr)
HR (1) HRP20080529T3 (fr)
IL (1) IL183666A (fr)
MA (1) MA29154B1 (fr)
MX (1) MX2007007228A (fr)
MY (1) MY143677A (fr)
NO (1) NO20073368L (fr)
NZ (1) NZ554732A (fr)
PE (1) PE20060771A1 (fr)
PL (1) PL1831237T3 (fr)
PT (1) PT1831237E (fr)
RS (1) RS50629B (fr)
SI (1) SI1831237T1 (fr)
TW (1) TWI326687B (fr)
UA (1) UA86119C2 (fr)
WO (1) WO2006065525A1 (fr)
ZA (1) ZA200705019B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2652633C (fr) * 2006-06-21 2014-03-25 Eli Lilly And Company Formes crystallines de promedicament amide gemcitabine, compositions et utilisation de celles-ci
TWI436775B (zh) 2007-08-24 2014-05-11 Oncotherapy Science Inc 以抗原胜肽合併化療藥劑治療胰臟癌
CN101525361B (zh) * 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
CA2890359A1 (fr) 2012-11-07 2014-05-15 Zucai SUO Analogues arylamides substitues de gemcitabine
BR112015010941A2 (pt) 2012-11-13 2017-07-11 Boyen Therapeutics Inc pró-fármacos de gemcitabina e suas utilizações
US10059733B2 (en) 2014-03-03 2018-08-28 Nucorion Pharmaceuticals, Inc. Gemcitabine analogs
WO2016078160A1 (fr) * 2014-11-17 2016-05-26 常州方圆制药有限公司 Dérivé de cytidine et application de celui-ci
US10435429B2 (en) 2017-10-03 2019-10-08 Nucorion Pharmaceuticals, Inc. 5-fluorouridine monophosphate cyclic triester compounds
US11427550B2 (en) 2018-01-19 2022-08-30 Nucorion Pharmaceuticals, Inc. 5-fluorouracil compounds
KR20200118827A (ko) 2018-02-02 2020-10-16 마베릭스 온콜로지, 잉크. 젬시타빈 모노포스페이트의 소분자 약물 컨쥬게이트
JP2021522331A (ja) * 2018-04-26 2021-08-30 ナノメッド ホールディングス プロプライエタリー リミテッド ジェムシタビン両親媒性プロドラッグ
CN108864250A (zh) * 2018-05-29 2018-11-23 北京大学 一种FAPα酶敏感的吉西他滨前体药物及其制备方法和应用
KR20210057025A (ko) * 2018-08-03 2021-05-20 셀릭스 바이오 프라이빗 리미티드 암의 치료를 위한 조성물 및 방법
WO2021216427A1 (fr) 2020-04-21 2021-10-28 Ligand Pharmaceuticals, Inc. Composés de promédicaments nucléotidiques
PL442924A1 (pl) * 2022-11-23 2024-05-27 Politechnika Śląska Prolek - glikokoniugat pochodny gemcytabiny, jako związek o działaniu przeciwnowotworowym, sposób otrzymywania i zastosowanie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
RU2131880C1 (ru) * 1992-06-22 1999-06-20 Эли Лилли Энд Компани Способ получения обогащенных бета-аномером нуклеозидов
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
GB2321454A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Gemcitabine esters and amides
DE69812934T2 (de) * 1997-01-24 2004-01-29 Conpharma As Oslo Gemcitabin-derivate
US6624142B2 (en) * 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6376470B1 (en) * 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
US7265096B2 (en) * 2002-11-04 2007-09-04 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US7846436B2 (en) * 2003-11-28 2010-12-07 Chemgenes Corporation Oligonucleotides and related compounds

Also Published As

Publication number Publication date
CA2589850A1 (fr) 2006-06-22
IL183666A0 (en) 2007-09-20
ZA200705019B (en) 2008-10-29
JP2008524218A (ja) 2008-07-10
NZ554732A (en) 2010-09-30
MY143677A (en) 2011-06-30
NO20073368L (no) 2007-07-16
ES2310860T3 (es) 2009-01-16
KR100874052B1 (ko) 2008-12-12
TW200634023A (en) 2006-10-01
AU2005316922B2 (en) 2011-08-25
CA2589850C (fr) 2012-05-01
CY1108447T1 (el) 2014-04-09
DE602005009255D1 (de) 2008-10-02
AU2005316922A1 (en) 2006-06-22
BRPI0519117A2 (pt) 2008-12-23
RS50629B (sr) 2010-06-30
PT1831237E (pt) 2008-09-22
DK1831237T3 (da) 2008-10-27
EA011868B1 (ru) 2009-06-30
EA200701300A1 (ru) 2007-10-26
US7691827B2 (en) 2010-04-06
MX2007007228A (es) 2007-08-14
TWI326687B (en) 2010-07-01
SI1831237T1 (sl) 2009-02-28
CN101080417A (zh) 2007-11-28
EP1831237A1 (fr) 2007-09-12
PE20060771A1 (es) 2006-09-23
HRP20080529T3 (en) 2008-12-31
UA86119C2 (ru) 2009-03-25
MA29154B1 (fr) 2008-01-02
CN101080417B (zh) 2011-01-19
PL1831237T3 (pl) 2009-01-30
KR20070086308A (ko) 2007-08-27
AR055009A1 (es) 2007-08-01
WO2006065525A1 (fr) 2006-06-22
EP1831237B1 (fr) 2008-08-20
JP5022911B2 (ja) 2012-09-12
ATE405573T1 (de) 2008-09-15
US20090156547A1 (en) 2009-06-18
IL183666A (en) 2011-09-27

Similar Documents

Publication Publication Date Title
IL183666A0 (en) Amide prodrug of gemcitabine, compositions and use thereof
IL204977A0 (en) Amide inhibitors of voltage-gated sodium channels, compositions comprising the same and uses thereof
IL191937A0 (en) Levodopa prodrug mesylate, compositions thereof and uses thereof
HK1099927A1 (en) Levodopa derivatives, and compositions and uses thereof
IL189011A0 (en) COMPOSITIONS OF tRNA AND USES THEREOF
EP2061476A4 (fr) Compositions contenant de la cdp-choline et procédés d'utilisation de celles-ci
PL2335782T3 (pl) Zastosowanie kompozycji zawierającej HFCO-1233zd
IL190506A0 (en) Amide derivatives and pesticidal compositions containing the same
SI2057153T1 (sl) (3-ril-piperazin-1-il) derivati 6,7-dialkoksikuinazolin, 6,7-dialkoksiftalazin in 6,7-dialkoksiizokuinolin
ZA200704295B (en) Arthrospira-based compositions and uses thereof
ZA200700809B (en) Corrosion-inhibiting compositions and use thereof
EP1954685A4 (fr) Composes furoxane, compositions et procedes d'utilisation
IL182126A (en) Preparations containing and used in the history of 5-phenoxyalkoxypsoralen
SI1858481T1 (sl) Oftalmološki sestavki in njihova uporaba
EP1848438A4 (fr) Compositions de diaminophenothiazine et utilisations associees
EP1991059A4 (fr) Compositions insecticides et utilisations de celles-ci
HK1101136A1 (en) Compositions against sars-coronavirus and uses thereof
IL186337A0 (en) Stannsoporfin compositions and administration
GB2423081B (en) Pro-fragrance and pro-flavorant compositions
IL186606A0 (en) Compositions and uses of amooranin compounds
EP1937292A4 (fr) Compositions pharmaceutiques a base de lopap et leurs utilisations
ZA200707529B (en) Pro-fragrance and pro-flavorant compositions
EP1761244A4 (fr) Compositions à base d'isocyanate et utilisation de celles-ci
EP1865777A4 (fr) Compositions de stannsoporfine et administration
GB0424051D0 (en) Compounds and compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151130